ClinicalTrials.Veeva

Menu

Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers

Z

Zagazig University

Status

Completed

Conditions

Blood, Injection, Injury Type Phobia
Gastrointestinal Ulcer Haemorrhage
Adverse Reaction to Epinephrine

Treatments

Biological: Blood
Drug: Epinephrine

Study type

Interventional

Funder types

Other

Identifiers

NCT01560702
IRB#:278/12-3-2012

Details and patient eligibility

About

Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.

Full description

To test the hypothesis that endoscopic injection of autologous blood is superior to endoscopic injection of diluted epinephrine in controlling bleeding from gastroduodenal ulcers.

Enrollment

100 patients

Sex

All

Ages

16 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all adult patients with gastroduodenal ulcer

Exclusion criteria

  • Patients with non ulcer bleeding.
  • Patients with malignancy.
  • Patients with bleeding disorders or under coagulation therapy.
  • Patients with known allergy to epinephrine.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Autologous blood
Active Comparator group
Description:
Patients will be injected by autologous blood at the edge of actively bleeding ulcer
Treatment:
Biological: Blood
Epinephrine injection
Other group
Description:
Patients will be injected by diluted epinephrine at the edge of actively bleeding ulcer
Treatment:
Drug: Epinephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems